<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Neurosciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DE845E5-F9D0-407F-9741-10E54FDC0FE4"><gtr:id>7DE845E5-F9D0-407F-9741-10E54FDC0FE4</gtr:id><gtr:name>University of Maastricht</gtr:name><gtr:address><gtr:line1>Department of Paediatrics</gtr:line1><gtr:line2>Universiteitssingel 50</gtr:line2><gtr:postCode>6200MD</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/26573E07-D0E4-47F2-82C9-99BB73BB6B2A"><gtr:id>26573E07-D0E4-47F2-82C9-99BB73BB6B2A</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Blockley</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FK025716%2F1"><gtr:id>859E630C-23D4-448C-8C81-D78772CCD028</gtr:id><gtr:title>Next generation MRI technologies for measuring brain oxygen metabolism</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>EP/K025716/1</gtr:grantReference><gtr:abstractText>The revolution of imaging the function of the brain using MRI, rather than just its structure, was kick started by the discovery of the blood oxygenation level dependent (BOLD) effect more than twenty years ago. As its name suggests this effect is dependent on blood oxygenation and is therefore sensitive to the rate at which the brain is consuming energy by burning glucose and oxygen (oxygen metabolism). Whilst BOLD functional MRI (fMRI) has enabled great improvements in our knowledge about the localisation of function it remains a qualitative measure of brain activity. By measuring oxygen metabolism we can take a direct look at the metabolic workload required to sustain this brain activity. Quantitative measurements of oxygen metabolism are possible using two techniques: calibrated BOLD and quantitative BOLD. Unfortunately neither method has reached its full potential. This is due in part to the complexity of these methods and requirements to perform complicated breathing challenges involving carbon dioxide. In both cases specialist knowledge is required, limiting the application of these methods to a small number of methodological research centres. The aim of this proposal is to remove these barriers enabling a broad spectrum of users to take advantage of these methods. 

Calibrated BOLD enables changes in oxygen metabolism, which are caused by performing a task or experiencing a stimulus, to be measured. However, in the current implementation of this method the participant must breathe air with added carbon dioxide. As well as the discomfort this causes, such experiments are difficult and time consuming to set up. In this proposal this so-called 'calibration' will be replaced by a simple measurement of the intrinsic relaxation properties of tissue. At a stroke, the set up of complicated equipment is removed and gas breathing is no longer required. This technique has the potential to be a required part of every fMRI experiment as it enables changes in baseline physiology to be obtained in a simple and quick manner. Such changes in baseline physiology between subjects and sessions can confound the interpretation of fMRI experiments leading to incorrect inferences.

Quantitative BOLD enables resting baseline oxygen metabolism to be estimated by measuring the amount of oxygen extracted to serve metabolism (oxygen extraction fraction). The method relies on the theoretical understanding that the intrinsic relaxation properties of tissue are dependent on the total amount of deoxygenated haemoglobin that is present in the pixel being imaged. This is effectively dependent on the product of the blood volume and the oxygen extraction fraction. Therefore an accurate measurement of blood volume is critical for disentangling these effects. Currently this is achieved using a subtle signal variation predicted by theory. In this proposal blood volume will be measured using oxygen as a tracer. This new technique has the potential to realise much higher accuracy and reproducibility than the current method. It also fulfils an unmet need of the healthcare community: a measurement of resting oxygen metabolism. The only other established method to achieve this uses Positron Emission Tomography (PET). However, this method requires the use of three radioactive tracers and the associated dose of ionising radiation. The expense and complexity of this method means that there are very few sites within the UK that are able to perform such experiments. In contrast, MRI is widely available and most clinical sites have direct access to 100% oxygen within the imaging suite. Hence this method has the potential to vastly improve the diagnostic capability of the UK healthcare system at minimal expense.</gtr:abstractText><gtr:potentialImpactText>The research proposed in this application is predicted to impact a range of non-academic beneficiaries over the shorter and longer term. Short term benefits may include the development of improved BOLD methodologies that can be quantified in terms of oxygen metabolism. These will be achieved over the course of the study. The validation of these technologies will provide improved diagnostic methods and biomarkers of drug action. This could result in changes to clinical practice and facilitate drug discovery. However, such impacts are likely to be achieved over the longer term 

Patients, carers and families, the broader care community, research supporters/donors 
- Availability of improved BOLD methodologies for diagnosis in e.g. in ischaemic stroke but potentially a wide range of CNS disorders e.g. haemorrhagic stroke, chronic pain, neurodegenerative and psychiatric disease.
- Removes the necessity to undergo an uncomfortable respiratory challenge.
- Potential improvements in use of anaesthesia in clinical practice
- Potential for novel BOLD methodologies to facilitate the development of novel therapies for CNS disorders.

UK and international biotech/pharmaceutical industry
- Development of biomarkers of brain oxygen metabolism to support drug discovery for CNS disorders.
- Development of novel software for medical imaging companies.
- Potential to reposition drugs that have failed to provide efficacy in other conditions thus recovering R&amp;amp;D expenditure and increasing revenue. 

UK NHS/funding agencies
- Ability for measuring brain oxygen metabolism in normal fMRI centers.
- Availability of biomarkers/diagnostic tests to predict course of CNS disease and treatment options.
- Potential development of novel biomarkers to support clinical research/experimental medicine. 

The broader UK economy 
- Stimulating growth in development of novel treatments for CNS disorders and area from which pharma has withdrawn in recent years.
- Potentially new therapies for CNS disorders, thus reducing cost of caring for patients, supporting patients unable to work and reducing loss to economy due to loss of productive work years.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2013-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>977594</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Simulating dcFMRI using a detailed model of the BOLD signal</gtr:description><gtr:id>4DFF4F76-98C8-4CE9-81AD-BF220FB18D11</gtr:id><gtr:impact>This collaboration has resulted in the publication of one paper (http://dx.doi.org/10.1016/j.neuroimage.2016.01.021) so far.</gtr:impact><gtr:outcomeId>54576a446790b7.27560188-1</gtr:outcomeId><gtr:partnerContribution>Cardiff University - Applied the simulation code supplied by myself and my UCSD partners to investigate their dcFMRI method
UCSD - supplied computer simulation tools and advice/support with its application</gtr:partnerContribution><gtr:piContribution>Supplied computer simulation tools and advice/support with its application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Simulating dcFMRI using a detailed model of the BOLD signal</gtr:description><gtr:id>7B98FBFC-62E4-4211-A14D-98304DF71DA8</gtr:id><gtr:impact>This collaboration has resulted in the publication of one paper (http://dx.doi.org/10.1016/j.neuroimage.2016.01.021) so far.</gtr:impact><gtr:outcomeId>54576a446790b7.27560188-2</gtr:outcomeId><gtr:partnerContribution>Cardiff University - Applied the simulation code supplied by myself and my UCSD partners to investigate their dcFMRI method
UCSD - supplied computer simulation tools and advice/support with its application</gtr:partnerContribution><gtr:piContribution>Supplied computer simulation tools and advice/support with its application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Measuring oxygen metabolism using an asymmetric spin echo</gtr:description><gtr:id>3D87B682-0BA8-4C98-A4DA-B5E9DB8EB0D3</gtr:id><gtr:impact>Paper in preparation</gtr:impact><gtr:outcomeId>54576b9c4332b7.92255285-1</gtr:outcomeId><gtr:partnerContribution>Application of the method using partners automated gas delivery system for accurate hyperoxia gas administration to human subjects.</gtr:partnerContribution><gtr:piContribution>Support with implementation of asymmetric spin echo on partners MRI scanner. Advice and support with theoretical and methodological aspects of the project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>STEM Ambassador</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>26DE72D6-0A7D-48D0-90F6-4664F504E911</gtr:id><gtr:impact>The STEM ambassador programme is a scheme to train scientists to engage with schools. This is an ongoing activity, but has so far resulted in two schools visits.
(1) Can we take pictures of our brains? - presentation to year 1 (3 classes)
(2) What does a Scientist do? - presentation to Foundation class</gtr:impact><gtr:outcomeId>58bd40c183b6d7.65906977</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary school visits</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>220633A4-33B3-489B-AA55-80CA32567BE5</gtr:id><gtr:impact>I visit Uffington C of E Primary school to assist in the delivery of science teaching as part of their gifted and talented programme. So far these events have involved me discussing scientific principles with pupils, designing practical demonstrations and performing scientific experiments. These visit are always very interactive. The children have lots of ideas and I hope the presence of a working scientist serves to inspire them to pursue a career in a STEM subject.</gtr:impact><gtr:outcomeId>56d8184951f612.17765797</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>We have had interest in these techniques from other laboratories and companies. In particular we have worked with researchers from other institutions both within the UK (Cardiff University) and internationally (University of Calgary, UCSD) to further develop these techniques. In addition during regular meetings with our industrial collaborator Siemens Healthineers we are able to discuss our portfolio of techniques.

We are currently acquiring measurements of resting oxygen metabolism in patients with acute stroke, traumatic brain injury, subarachnoid haemorrhage and brain tumour. It is possible that this could have impact in the care of such patients. We are also collaborating with neuroscientists interested in anaesthesia to better understand loss of consciousness, which may also improve human health.</gtr:description><gtr:id>A33D53D5-B5F8-4EC2-85CB-C3C87B384B42</gtr:id><gtr:impactTypes/><gtr:outcomeId>545790237e5c17.51295511</gtr:outcomeId><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This study is largely methodological in nature with the aim of developing new tools for the measurement of oxygen metabolism in human subjects or patients.

To date we have developed a new technique that is sensitive to blood oxygenation in the brain, but not other sources of signal caused by imperfections in the MRI magnetic field. We have used this new technique to measure oxygen metabolism in the brain, whilst marginalising confounding sources of signal, and we have tested this technique in a cohort of healthy subjects. We have now completed a proof of concept study in acute stroke patients with very positive results. We hope that this method will help clinicians understand the progression of stroke and in the longer term inform treatment decisions. We are also investigating the utility of our technique in traumatic brain injury, subarachnoid haemorrhage and brain tumour.

In addition we continue to pursue development of a technique to measure changes in oxygen metabolism following a stimulus. Such a technique would be very useful in neuroscientific applications. We are currently investigating the problems with the conventional approach with a view to making future comparisons with our new improved technique.</gtr:description><gtr:exploitationPathways>We will continue to collaborate with clinical colleagues to improve the effectiveness of our new technique and to examine its utility in the treatment of stroke.</gtr:exploitationPathways><gtr:id>1C3FD75F-F01A-4EC3-9E29-7722A85176A6</gtr:id><gtr:outcomeId>5457923deb6226.12728144</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.ndcn.ox.ac.uk/research/fmri-physiology</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Simulation code was developed to investigate sources of systematic bias in calibrated BOLD functional MRI (fMRI) based mapping of the oxygen extraction fraction. However, this tool may be useful for improving our understanding of other BOLD based fMRI methods.</gtr:description><gtr:id>A949D5CE-1725-4292-B9EA-5E4926C77514</gtr:id><gtr:impact>Simulation code has been used by collaborators at Cardiff University in the following publication (Merola A, Murphy K, Stone AJ, Germuska MA, Griffeth VEM, Blockley NP, Buxton RB, Wise RG. Measurement of oxygen extraction fraction (OEF): An optimized BOLD signal model for use with hypercapnic and hyperoxic calibration. Neuroimage 2016;129:159-174. doi: 10.1016/j.neuroimage.2016.01.021.)</gtr:impact><gtr:outcomeId>56d819e1abad25.98197838</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A tool for investigating systematic bias in BOLD based MRI methods: An implementation of the detailed BOLD signal model</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>https://ora.ox.ac.uk/objects/uuid:cbee3305-4b21-4445-b2e0-5f86187c82d6</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The data in this archive was acquired during the development of the GASE (Gradient-Echo Slice Excitation Imaging Asymmetric Spin Echo; GESEPI ASE) technique. GASE can be used to map the reversible transverse relaxation rate R2' (a contrast used in Magnetic Resonance Imaging - MRI) without the need to separately acquire a magnetic field map to correct for residual magnetic field gradients not compensated by magnet shimming. This technique has application in measuring blood oxygenation using the quantitative BOLD (baseline levels) and calibrated BOLD (dynamic changes) techniques as well as iron deposition.</gtr:description><gtr:id>427A39B4-A647-4BB7-9E33-93F689EF7ED1</gtr:id><gtr:impact>None to date. Has been downloaded 31 times.</gtr:impact><gtr:outcomeId>56d819a2a6d735.12481084</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data acquired during the development of an R2' mapping technique with prospective correction for macroscopic magnetic field gradients</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>https://ora.ox.ac.uk/objects/uuid:fe4cf726-24e1-4bc3-bc24-5c246515d131</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Data associated with publication (Stone AJ, Blockley NP. A streamlined acquisition for mapping baseline brain oxygenation using quantitative BOLD. Neuroimage 2017;147:79-88. doi: 10.1016/j.neuroimage.2016.11.057.)</gtr:description><gtr:id>96A62F40-33B0-426D-8373-303F5E5943B0</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>58bd418702bf20.16907790</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data acquired to demonstrate a streamlined approach to mapping and quantifying brain oxygenation using quantitative BOLD</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>https://ora.ox.ac.uk/objects/uuid:177afade-8599-4d9c-959e-26e1426ec486</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Data related to a forth coming publication.</gtr:description><gtr:id>649FA4A6-8651-4524-B6AB-7DC5FFED6E3C</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>58bd425767c275.53286707</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data acquired to investigate new approaches to cerebrovascular reactivity mapping using MRI</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D9D33B24-7CA8-45EC-9967-AE2367558DEF</gtr:id><gtr:title>A novel Bayesian approach to accounting for uncertainty in fMRI-derived estimates of cerebral oxygen metabolism fluctuations.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39fbbd6a3046ceccdaeb1f0f4d6b0163"><gtr:id>39fbbd6a3046ceccdaeb1f0f4d6b0163</gtr:id><gtr:otherNames>Simon AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56d8150a4033b6.84071290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D5B07D7-7F47-4580-813D-077AF8C96C3D</gtr:id><gtr:title>The effect of diffusion on quantitative BOLD parameter estimates acquired with the asymmetric spin echo technique</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/978e60dba12b9d84b9a24a57bc6dd954"><gtr:id>978e60dba12b9d84b9a24a57bc6dd954</gtr:id><gtr:otherNames>Blockley N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd4686254a21.05578918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5029A4DF-D908-45E5-8969-6CEED13CFA8D</gtr:id><gtr:title>Serial quantification of brain oxygenation using streamlined-qBOLD in acute stroke patients</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cbcbe85d7b0842d2741864bc7d85602"><gtr:id>8cbcbe85d7b0842d2741864bc7d85602</gtr:id><gtr:otherNames>Stone AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd4620d17515.58237564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84B4C61B-2F9D-4953-ADEF-C07C4956984A</gtr:id><gtr:title>A multi-field comparison of gas calibrated fMRI</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30dfaee15d32b4762c93f2306a338cc3"><gtr:id>30dfaee15d32b4762c93f2306a338cc3</gtr:id><gtr:otherNames>Hare HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5457672c275c85.87818856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>909D2184-66E9-49B8-9E09-C78C9412641D</gtr:id><gtr:title>Flow related changes in oxygen extraction fraction detected using streamlined-qBOLD</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0faa7f8eec7970b9b2b3a1dd5c6ca15"><gtr:id>f0faa7f8eec7970b9b2b3a1dd5c6ca15</gtr:id><gtr:otherNames>Stone A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd464e310d17.68868518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>797CBA88-2B8A-4762-8E7C-51735C440877</gtr:id><gtr:title>Prospective Motion Correction with EPI Volume Navigators for Chemical Exchange Saturation Transfer (CEST) Imaging.</gtr:title><gtr:parentPublicationTitle>N/A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/720c96d82bcc916921df9a628f20ae16"><gtr:id>720c96d82bcc916921df9a628f20ae16</gtr:id><gtr:otherNames>Frost R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54575e0ecbd7f4.84510753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F3975D8-6921-438A-9EE9-0C7E3CDCE23F</gtr:id><gtr:title>Gas-free calibrated fMRI with a correction for vessel-size sensitivity.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b12ad9130286a615e5006d56bd9196ed"><gtr:id>b12ad9130286a615e5006d56bd9196ed</gtr:id><gtr:otherNames>Berman AJL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a6f2cee16f151.02040240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A99C80E-4785-48C2-A490-F13C0D4F2AD5</gtr:id><gtr:title>Hemispheric asymmetry in cerebrovascular reactivity of the human primary motor cortex: an in vivo study at 7 T.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2158881a3f9b34f59f041345699964fc"><gtr:id>2158881a3f9b34f59f041345699964fc</gtr:id><gtr:otherNames>Driver ID</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>56d81509e393d9.55354298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32D4AA75-1EC2-4A27-94B1-7FFEA0001E9B</gtr:id><gtr:title>Tissue Outcome Prediction in Ischaemic Stroke with Diffusion, Perfusion and pH Sensitive CEST Imaging at Three Different Time Points.</gtr:title><gtr:parentPublicationTitle>N/A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5eaabdf0b368a2fefb868d688ea23eb"><gtr:id>c5eaabdf0b368a2fefb868d688ea23eb</gtr:id><gtr:otherNames>Levman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54576323788eb5.44071201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC738398-3666-4627-8944-82EB3C1CC1E2</gtr:id><gtr:title>Serial PH-Weighted Imaging Using Amide Proton Transfer in Acute Ischemic Stroke.</gtr:title><gtr:parentPublicationTitle>N/A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4df30624caa03327f5e3c71ca6e8ebb"><gtr:id>a4df30624caa03327f5e3c71ca6e8ebb</gtr:id><gtr:otherNames>Harston G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5457637c9a78b9.97945161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14CDC876-A498-419A-AC29-FE8F44A0DA26</gtr:id><gtr:title>Improving the specificity of R2' to the deoxyhaemoglobin content of brain tissue: Prospective correction of macroscopic magnetic field gradients.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bdf054f68b1bbf4e0074774cec6578"><gtr:id>a8bdf054f68b1bbf4e0074774cec6578</gtr:id><gtr:otherNames>Blockley NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>585d6caf2c5ac1.59916348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E00B146-9475-4462-B87C-1754A6E43BE6</gtr:id><gtr:title>Measurement of oxygen extraction fraction (OEF): an optimised BOLD signal model for use with hypercapnic and hyperoxic calibration</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9386086c7f3792bf67d1d01490d8a15"><gtr:id>b9386086c7f3792bf67d1d01490d8a15</gtr:id><gtr:otherNames>Merola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>58bd45d60ec695.15992557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F6AA71C-C992-4118-BE8C-865A9C07DA45</gtr:id><gtr:title>Sources of systematic error in calibrated BOLD based mapping of baseline oxygen extraction fraction.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bdf054f68b1bbf4e0074774cec6578"><gtr:id>a8bdf054f68b1bbf4e0074774cec6578</gtr:id><gtr:otherNames>Blockley NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56d8150a1a9ba7.23069432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0F57A74-2F11-4D12-947D-3F69AB7A0F11</gtr:id><gtr:title>Can Nuclear Overhauser Enhancement Mediated Chemical Exchange Saturation Transfer (NOE-CEST) Offer a New Insight in Acute Stroke Diagnosis?</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131ce11cb88318df35a8fb2fd34fa0ed"><gtr:id>131ce11cb88318df35a8fb2fd34fa0ed</gtr:id><gtr:otherNames>Tee YK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>58bd454246eb98.62453821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15BCF34E-91E3-4D58-8409-3C8FE89E0C45</gtr:id><gtr:title>A streamlined approach to mapping the oxygen extraction fraction (OEF) and deoxygenated blood volume (DBV) using the quantitative BOLD technique</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cbcbe85d7b0842d2741864bc7d85602"><gtr:id>8cbcbe85d7b0842d2741864bc7d85602</gtr:id><gtr:otherNames>Stone AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>58bd4581c4cdd3.91151216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F88A8EA-2EDD-43F8-A37C-2EF27B4545EE</gtr:id><gtr:title>Assessing Different Amide Proton Transfer (APT) Quantification Methods in Hyper-Acute Stroke Patients.</gtr:title><gtr:parentPublicationTitle>N/A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131ce11cb88318df35a8fb2fd34fa0ed"><gtr:id>131ce11cb88318df35a8fb2fd34fa0ed</gtr:id><gtr:otherNames>Tee YK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54576279ee5371.91225881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0957452E-2A6E-4C3E-9744-BF9268421C76</gtr:id><gtr:title>Measurement of oxygen extraction fraction (OEF): An optimized BOLD signal model for use with hypercapnic and hyperoxic calibration.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9386086c7f3792bf67d1d01490d8a15"><gtr:id>b9386086c7f3792bf67d1d01490d8a15</gtr:id><gtr:otherNames>Merola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56d8150a6b95c2.33394899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6455EA5-808C-4225-A958-0C2FC2466A52</gtr:id><gtr:title>Rapid cerebrovascular reactivity mapping: Enabling vascular reactivity information to be routinely acquired.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bdf054f68b1bbf4e0074774cec6578"><gtr:id>a8bdf054f68b1bbf4e0074774cec6578</gtr:id><gtr:otherNames>Blockley NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a2fec218365a0.63180605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6D6702C-6642-469B-8E96-2907806CBACC</gtr:id><gtr:title>The relationship between blood flow impairment and oxygen depletion in acute ischemic stroke imaged with magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26436c5a220ef93301ada04b32f1b546"><gtr:id>26436c5a220ef93301ada04b32f1b546</gtr:id><gtr:otherNames>Seiler A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>5aa13c6567cd60.27997546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>997819B2-D20A-4878-95C6-72FBDB86E50D</gtr:id><gtr:title>Calibrating the BOLD response without administering gases: comparison of hypercapnia calibration with calibration using an asymmetric spin echo.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bdf054f68b1bbf4e0074774cec6578"><gtr:id>a8bdf054f68b1bbf4e0074774cec6578</gtr:id><gtr:otherNames>Blockley NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>54416bc9f1f968.40883757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83CFC731-EA35-40F4-9F61-0EEA48705C6C</gtr:id><gtr:title>Multiparametric measurement of cerebral physiology using calibrated fMRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02bb247de007f772243f7fadd1af6c1e"><gtr:id>02bb247de007f772243f7fadd1af6c1e</gtr:id><gtr:otherNames>Bright MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a67085fe03324.91448411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2511A0C5-F4AC-4B81-A24A-EC06EF0F93DA</gtr:id><gtr:title>Improving the specificity of R2' to mesoscopic magnetic field inhomogeneity by compensating for through-slice magnetic field gradients during image acquisition</gtr:title><gtr:parentPublicationTitle>Annual meeting of the International Society of Magnetic Resonance in Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bdf054f68b1bbf4e0074774cec6578"><gtr:id>a8bdf054f68b1bbf4e0074774cec6578</gtr:id><gtr:otherNames>Blockley NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>544172c57054b2.66944114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78B5A729-3781-4F43-87B6-EC5E48A02178</gtr:id><gtr:title>Investigating the field-dependence of the Davis model: Calibrated fMRI at 1.5, 3 and 7T.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30dfaee15d32b4762c93f2306a338cc3"><gtr:id>30dfaee15d32b4762c93f2306a338cc3</gtr:id><gtr:otherNames>Hare HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>doi_55f9839830a537d8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>972730AA-8626-4D97-BB24-BA2AC421E32D</gtr:id><gtr:title>Generating Quantitative pH Maps in Hyper-Acute Stroke Patients Using Amide Proton Transfer (APT) Imaging.</gtr:title><gtr:parentPublicationTitle>N/A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131ce11cb88318df35a8fb2fd34fa0ed"><gtr:id>131ce11cb88318df35a8fb2fd34fa0ed</gtr:id><gtr:otherNames>Tee YK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545762087a48d1.58145374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5CED4B1-F46A-44DB-A355-452F4B46B585</gtr:id><gtr:title>Comparing different analysis methods for quantifying the MRI amide proton transfer (APT) effect in hyperacute stroke patients.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131ce11cb88318df35a8fb2fd34fa0ed"><gtr:id>131ce11cb88318df35a8fb2fd34fa0ed</gtr:id><gtr:otherNames>Tee YK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>54575ab8d982d2.13993720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B2D77FA-5A7C-44A2-9162-A5BF6B5F2D6E</gtr:id><gtr:title>Calibrated fMRI at 1.5, 3 and 7T: a comparative study</gtr:title><gtr:parentPublicationTitle>N/A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30dfaee15d32b4762c93f2306a338cc3"><gtr:id>30dfaee15d32b4762c93f2306a338cc3</gtr:id><gtr:otherNames>Hare HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545766d7519192.97601322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8724EC0D-8FA2-43DD-B400-97863847EEB8</gtr:id><gtr:title>Clinically relevant rapid 3D CEST imaging with hexagonal spoiling, optimised B1 and symmetric z-spectrum sampling</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca9f47c725722aa082952f88e34373e0"><gtr:id>ca9f47c725722aa082952f88e34373e0</gtr:id><gtr:otherNames>Brand R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd46c11ad3e4.78771209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5283087-76F2-4400-98CE-A08BC607A350</gtr:id><gtr:title>Identifying the ischaemic penumbra using pH-weighted magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7392f9981aac73a86ba984116a32ef"><gtr:id>5e7392f9981aac73a86ba984116a32ef</gtr:id><gtr:otherNames>Harston GW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>54575d0378ceb9.19671147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90AF8921-BFBD-499A-AB7B-6202CD5615E4</gtr:id><gtr:title>A streamlined acquisition for mapping baseline brain oxygenation using quantitative BOLD.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cbcbe85d7b0842d2741864bc7d85602"><gtr:id>8cbcbe85d7b0842d2741864bc7d85602</gtr:id><gtr:otherNames>Stone AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>58bd3df061ae86.64679416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2869FCD-6DED-4CF5-9E2C-B171D1913D95</gtr:id><gtr:title>Measuring absolute CMRO2 using Asymmetric Spin Echo and hyperoxic calibrated BOLD</gtr:title><gtr:parentPublicationTitle>Annual meeting of the International Society of Magnetic Resonance in Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cbcbe85d7b0842d2741864bc7d85602"><gtr:id>8cbcbe85d7b0842d2741864bc7d85602</gtr:id><gtr:otherNames>Stone AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>544171ac5260e7.59728954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30A40627-4611-468D-BA03-8F90A5B49D75</gtr:id><gtr:title>Investigating the field-dependence of the Davis model: Calibrated fMRI at 1.5, 3 and 7 tesla</gtr:title><gtr:parentPublicationTitle>Annual meeting of the International Society of Magnetic Resonance in Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30dfaee15d32b4762c93f2306a338cc3"><gtr:id>30dfaee15d32b4762c93f2306a338cc3</gtr:id><gtr:otherNames>Hare HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5441724f46e415.05624059</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/K025716/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>A759BB04-AFFE-4780-BD31-9A2707BC44BA</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical Imaging</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>